Jeil Pharm (002620) — Cash Flow Quality Index
Jeil Pharm (002620) has a Cash Flow Quality Index of 0.27x as of December 2025. Operating cash flow of ₩1.97 Billion is below net income of ₩7.31 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Jeil Pharm long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jeil Pharm Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Jeil Pharm across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002620 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jeil Pharm (2011–2025)
Year-by-year earnings quality comparison for Jeil Pharm. For live market cap and the full company financial profile, see 002620 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₩390.26 Million | ₩14.64 Billion | ▲ +101.3% |
| 2020 | -2.07x | ₩-23.67 Billion | ₩11.43 Billion | ▼ -326.5% |
| 2018 | -0.49x | ₩-3.43 Billion | ₩7.07 Billion | ▼ -4365.5% |
| 2017 | 0.01x | ₩5.92 Billion | ₩520.35 Billion | ▼ -99.2% |
| 2016 | 1.44x | ₩11.36 Billion | ₩7.89 Billion | ▲ +412.1% |
| 2015 | 0.28x | ₩2.74 Billion | ₩9.76 Billion | ▲ +179.6% |
| 2012 | -0.35x | ₩-3.94 Billion | ₩11.17 Billion | ▼ -140.4% |
| 2011 | 0.87x | ₩23.63 Billion | ₩27.01 Billion | — |